New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications
Abstract
:1. Introduction
2. Results
2.1. Characterization of DIO-NPs
2.2. Cytotoxicity of DIO-NPs on PANC-1 Cells
2.3. Cellular Uptake of DIO-NPs
2.4. Biogenesis and Subcellular Localization of Lysosomes
2.5. MR Contrast
2.6. Potential Toxic Effects of DIO-NPs
2.7. Alterations in Protein Expression of Heat Shock Proteins and Tumor Suppressor p53
3. Discussion
4. Materials and Methods
4.1. Synthesis and Characterization of Dextran-Coated ɣ-Fe2O3 Nanoparticles
4.2. Preparation of NP Suspension
4.3. Measurement of Relaxivity (r1 and r2)
4.4. Cell Culture and Treatment Conditions
4.5. Cell Viability Assay
4.6. Iron Uptake Quantification
4.6.1. DAB-Enhanced Perls’ Prussian Blue Staining
4.6.2. Pearl’s Prussian Blue Colorimetry
4.6.3. Relaxometry Technique
4.7. Lysosomal Labeling
4.8. MRI Analyses
4.9. Toxicity Assessment
4.9.1. ROS Production
4.9.2. Intracellular GSH Content
4.9.3. Lipid Peroxidation
4.9.4. LDH Assay
4.9.5. Caspase-1 Activity
4.10. Western Blot Analysis
4.11. Statistical Analysis
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Karamitopoulou, E. Molecular Pathology of Pancreatic Cancer. Cancers 2022, 14, 1523. [Google Scholar] [CrossRef] [PubMed]
- Costache, M.I.; Costache, C.A.; Dumitrescu, C.I.; Tica, A.A.; Popescu, M.; Băluță, E.A.; Anghel, A.C.; Săftoiu, A.; Dumitrescu, D. Which is the Best Imaging Method in Pancreatic Adenocarcinoma Diagnostic and Staging-CT, MRI and EUS? Curr. Health Sci. J. 2017, 43, 132–136. [Google Scholar] [PubMed]
- Shi, S.; Yu, X. Selecting chemotherapy for pancreatic cancer: Far away or so close? Semin. Oncol. 2019, 46, 39–47. [Google Scholar] [CrossRef] [PubMed]
- Tsai, S.; Evans, D.B. Evolution of the management of resectable pancreatic cancer. J. Oncol. Pract. 2016, 12, 772–778. [Google Scholar] [CrossRef]
- Garrido-Laguna, I.; Hidalgo, M. Pancreatic cancer: From state-of-the-art treatments to promising novel therapies. Nat. Rev. Clin. Oncol. 2015, 12, 319–334. [Google Scholar] [CrossRef]
- Swayden, M.; Iovanna, J.; Soubeyran, P. Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotype. Helyon 2018, 4, e01055. [Google Scholar] [CrossRef]
- Capurso, G.; Sette, C. Drug resistance in pancreatic cancer: New player caught in act. EBioMedicine 2019, 40, 30–40. [Google Scholar] [CrossRef]
- Xue, Y.; Gao, Y.; Meng, F.; Luo, L. Recent progress of nanotechnology-based theranostic systems in cancer treatments. Cancer Biol. Med. 2021, 18, 336–351. [Google Scholar] [CrossRef]
- Brachi, G.; Bussolino, F.; Ciardelli, G.; Mattu, C. Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma. Front. Bioeng. Biotechnol. 2019, 7, 307. [Google Scholar] [CrossRef]
- Etemadi, H.; Buchanan, J.K.; Kandile, N.G.; Plieger, P.G. Iron Oxide Nanoparticles: Physicochemical Characteristics and Historical Developments to Commercialization for Potential Technological Applications. ACS Biomater. Sci. Eng. 2021, 7, 5432–5450. [Google Scholar] [CrossRef]
- Malekigorji, M.; Alfahad, M.; Lin, P.K.T.; Jones, S.; Curtis, A.; Hoskins, C. Thermally triggered theranostics for pancreatic cancer therapy. Nanoscale 2017, 9, 12735–12745. [Google Scholar] [CrossRef] [PubMed]
- Deng, L.; Ke, X.; He, Z.; Yang, D.; Gong, H.; Zhang, Y.; Jing, X.; Yao, J.; Chen, J. An MSLN-targeted multifunctional nanoimmunoliposome for MRI and targeting therapy in pancreatic cancer. Int. J. Nanomed. 2012, 7, 5053–5065. [Google Scholar]
- Lee, G.Y.; Qian, W.P.; Wang, L.; Wang, Y.A.; Staley, C.A.; Satpathy, M.; Nie, S.; Mao, H.; Yang, L. Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer. ACS Nano 2013, 7, 2078–2089. [Google Scholar] [CrossRef] [PubMed]
- Zhou, H.Y.; Qian, W.P.; Uckun, F.M.; Wang, L.; Wang, Y.A.; Chen, H.; Kooby, D.; Yu, Q.; Lipowska, M.; Staley, C.A.; et al. IGF1 receptor targeted theranostic nanoparticles for targeted and image-guided therapy of pancreatic cancer. ACS Nano 2015, 9, 7976–7991. [Google Scholar] [CrossRef]
- Mahajan, U.M.; Teller, S.; Sendler, M.; Palankar, R.; van den Brandt, C.; Schwaiger, T.; Kühn, J.P.; Ribback, S.; Glöckl, G.; Evert, M.; et al. Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer. Gut 2016, 65, 1838–1849. [Google Scholar] [CrossRef]
- Zhu, L.; Mao, H.; Yang, L. Advanced iron oxide nanotheranostics for multimodal and precision treatment of pancreatic ductal adenocarcinoma. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2022, 14, e1793. [Google Scholar] [CrossRef]
- Fernández-Acosta, R.; Iriarte-Mesa, C.; Alvarez-Alminaque, D.; Hassannia, B.; Wiernicki, B.; Díaz-García, A.M.; Vandenabeele, P.; Vanden Berghe, T.; Pardo Andreu, G.L. Novel Iron Oxide Nanoparticles Induce Ferroptosis in a Panel of Cancer Cell Lines. Molecules 2022, 27, 3970. [Google Scholar] [CrossRef]
- Cheng, K.; Cheng, Z. Chapter 15. Diagnostic Applications. In Adverse Effects of Engineered Nanomaterials, 1st ed.; Fadeel, B., Pietroiusti, A., Shvedova, A., Eds.; Academic Press: Cambridge, MA, USA; Elsevier: Amsterdam, The Netherlands, 2012; pp. 265–284. [Google Scholar]
- Nelson, N.R.; Port, J.D.; Pandey, M.K. Use of Superparamagnetic Iron Oxide Nanoparticles (SPIONs) via Multiple Imaging Modalities and Modifications to Reduce Cytotoxicity: An Educational Review. J. Nanotheranostics 2020, 1, 105–135. [Google Scholar] [CrossRef]
- Maurizi, L.; Papa, A.L.; Dumont, L.; Bouyer, F.; Walker, P.; Vandroux, D.; Millot, N. Influence of Surface Charge and Polymer Coating on Internalization and Biodistribution of Polyethylene Glycol-Modified Iron Oxide Nanoparticles. J. Biomed. Nanotechnol. 2015, 11, 126–136. [Google Scholar] [CrossRef]
- Wahajuddin, A.S. Superparamagnetic iron oxide nanoparticles: Magnetic nanoplatforms as drug carriers. Int. J. Nanomed. 2012, 7, 3445–3471. [Google Scholar] [CrossRef]
- Wáng, Y.X.; Idée, J.M. A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging. Quant. Imag. Med. Surg. 2017, 7, 88–122. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhang, C.; Yan, Y.; Zou, Q.; Chen, J.; Li, C. Superparamagnetic iron oxide nanoparticles for MR imaging of pancreatic cancer: Potential for early diagnosis through targeted strategies. Asia-Pac. J. Clin. Oncol. 2016, 12, 13–21. [Google Scholar] [CrossRef] [PubMed]
- Feng, Q.; Liu, Y.; Huang, J.; Chen, K.; Huang, J.; Xiao, K. Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings. Sci. Rep. 2018, 8, 2082. [Google Scholar] [CrossRef] [PubMed]
- Patil, R.M.; Thorat, N.D.; Shete, P.B.; Bedge, P.A.; Gavde, S.; Joshi, M.G.; Tofail, S.A.M.; Bohara, R.A. Comprehensive cytotoxicity studies of superparamagnetic iron oxide nanoparticles. Biochem. Biophys. Rep. 2018, 13, 63–72. [Google Scholar] [CrossRef] [PubMed]
- Vakili-Ghartavol, R.; Momtazi-Borojeni, A.A.; Vakili-Ghartavol, Z.; Aiyelabegan, H.T.; Jaafari, M.R.; Rezayat, S.M.; Arbabi Bidgoli, S. Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues. Artif. Cells Nanomed. Biotechnol. 2020, 48, 443–451. [Google Scholar] [CrossRef]
- Unterweger, H.; Janko, C.; Schwarz, M.; Dézsi, L.; Urbanics, R.; Matuszak, J.; Cicha, I. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: A biocompatible, size-tunable contrast agent for magnetic resonance imaging. Int. J. Nanomed. 2017, 12, 5223–5238. [Google Scholar] [CrossRef]
- Yarjanli, Z.; Ghaedi, K.; Esmaeili, A.; Rahgozar, S.; Zarrabi, A. Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation. BMC Neurosci. 2017, 18, 51. [Google Scholar] [CrossRef]
- Simberg, D.; Zhang, W.M.; Merkulov, S.; McCrae, K.; Park, J.H.; Sailor, M.J.; Ruoslahti, E. Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo. J. Control. Release 2009, 140, 301–305. [Google Scholar] [CrossRef]
- Albukhaty, S.; Al-Musawi, S.; Abdul Mahdi, S.; Sulaiman, G.M.; Alwahibi, M.S.; Dewir, Y.H.; Soliman, D.A.; Rizwana, H. Investigation of Dextran-Coated Superparamagnetic Nanoparticles for Targeted Vinblastine Controlled Release, Delivery, Apoptosis Induction, and Gene Expression in Pancreatic Cancer Cells. Molecules 2020, 25, 4721. [Google Scholar] [CrossRef]
- Darwish, M.S.A.; Al-Harbi, L.M.; Bakry, A. Synthesis of magnetite nanoparticles coated with polyvinyl alcohol for hyperthermia application. J. Therm. Anal. Calorim. 2022, 147, 11921–11930. [Google Scholar] [CrossRef]
- Al-Harbi, L.M.; Darwish, M.S. Functionalized iron oxide nanoparticles: Synthesis through ultrasonic-assisted co-precipitation and performance as hyperthermic agents for biomedical applications. Heliyon 2022, 8, e09654. [Google Scholar] [CrossRef] [PubMed]
- Nikitin, M.P.; Orlov, A.V.; Znoyko, S.L.; Bragina, V.A.; Gorshkov, B.G.; Ksenevich, T.I.; Cherkasov, V.R.; Nikitin, P.I. Multiplex biosensing with highly sensitive magnetic nanoparticle quantification method. J. Magn. Magn. Mater. 2018, 459, 260–264. [Google Scholar] [CrossRef]
- Kim, W.; Suh, C.Y.; Cho, S.W.; Roh, K.M.; Kwon, H.; Song, K.; Shon, I.J. A new method for the identification an quantification of magnetite-maghemite mixture using conventional X-ray diffraction technique. Talanta 2012, 94, 348–352. [Google Scholar] [CrossRef] [PubMed]
- Teja, A.S.; Koh, P.Y. Synthesis, properties, and applications of magnetic iron oxide nanoparticles. Prog. Cryst. Growth Charact. Mater. 2009, 55, 22–45. [Google Scholar] [CrossRef]
- Prodan, A.M.; Ciobanu, C.S.; Popa, C.L.; Iconaru, S.L.; Predoi, D. Toxicity Evaluation following Intratracheal Instillation of Iron Oxide in a Silica Matrix in Rats. BioMed Res. Int. 2014, 2014, 134260. [Google Scholar] [CrossRef] [PubMed]
- Ryu, J.H.; Jiwpanich, S.; Chacko, R.; Bickerton, S.; Thayumanavan, S. Surface-Functionalizable Polymer Nano-gels with Facile Hydrophobic Guest Encapsulation Capabilities. J. Am. Chem. Soc. 2010, 132, 8246–8247. [Google Scholar] [CrossRef]
- Ryu, J.H.; Chacko, R.T.; Jiwpanich, S.; Bickerton, S.; Babu, R.P.; Thayumanavan, S. Self-Cross-Linked Polymer Nanogels: A Versatile Nanoscopic Drug Delivery Platform. J. Am. Chem. Soc. 2010, 132, 17227–17235. [Google Scholar] [CrossRef]
- Aktan, B.; Chambre, L.; Sanyal, R.; Sanyal, A. “Clickable” Nanogels via Thermally Driven Self-Assembly of Polymers: Facile Access to Targeted Imaging Platforms using Thiol–Maleimide Conjugation. Biomacromolecules 2017, 18, 490–497. [Google Scholar] [CrossRef]
- Darwish, M.S.A.; Stibor, I. Pentenoic Acid-Stabilized Magnetic Nanoparticles for Nanomedicine Applications. J. Dispers. Sci. Technol. 2016, 37, 1793–1798. [Google Scholar] [CrossRef]
- Kmita, A.; Lachowicz, D.; Żukrowski, J.; Gajewska, M.; Szczerba, W.; Kuciakowski, J.; Zapo-toczny, S.; Sikora, M. One-step synthesis of long term stable superparamagnetic colloid of zinc ferrite nanorods in water. Materials 2019, 12, 1048. [Google Scholar] [CrossRef]
- Alimohammadi, V.; Seyyed Ebrahimi, S.A.; Kashanian, F.; Lalegani, Z.; Habibi-Rezaei, M.; Hamawandi, B. Hydrophobic Magnetite Nanoparticles for Bioseparation: Green Synthesis, Functionalization, and Characterization. Magnetochemistry 2022, 8, 143. [Google Scholar] [CrossRef]
- Kurchania, R.; Sawant, S.S.; Ball, R.J. Synthesis and characterization of magnetite/polyvinyl alcohol core-shell composite nanoparticles. J. Am. Ceram. Soc. 2014, 97, 3208–3215. [Google Scholar] [CrossRef]
- Gradiz, R.; Silva, H.C.; Carvalho, L.; Botelho, M.F.; Mota-Pinto, A. MIA PaCa-2 and PANC-1—Pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors. Sci. Rep. 2016, 6, 21648. [Google Scholar] [CrossRef]
- Nedelcu, A.; Mocan, T.; Grapa, C.; Mocan, L. Recent Advances in Nanoparticle-Mediated Diagnosis and the Treatment of Pancreatic Cancer. Int. J. Mol. Sci. 2021, 22, 8060. [Google Scholar] [CrossRef] [PubMed]
- Lafuente-Gómez, N.; Milán-Rois, P.; García-Soriano, D.; Luengo, Y.; Cordani, M.; Alarcón-Iniesta, H.; Salas, G.; Somoza, Á. Smart Modification on Magnetic Nanoparticles Dramatically Enhances Their Therapeutic Properties. Cancers 2021, 13, 4095. [Google Scholar] [CrossRef]
- Singh, N.; Jenkins, G.J.; Nelson, B.C.; Marquis, B.J.; Maffeis, T.G.; Brown, A.P.; Williams, P.M.; Wright, C.J.; Doak, S.H. The role of iron redox state in the genotoxicity of ultrafine superparamagnetic iron oxide nanoparticles. Biomaterials 2012, 33, 163–170. [Google Scholar] [CrossRef]
- Malhotra, N.; Lee, J.S.; Liman, R.A.D.; Ruallo, J.M.S.; Villaflores, O.B.; Ger, T.R.; Hsiao, C.D. Potential Toxicity of Iron Oxide Magnetic Nanoparticles: A Review. Molecules 2020, 25, 3159. [Google Scholar] [CrossRef]
- Valdiglesias, V.; Kiliç, G.; Costa, C.; Fernández-Bertólez, N.; Pásaro, E.; Teixeira, J.P.; Laffon, B. Effects of iron oxide nanoparticles: Cytotoxicity, genotoxicity, developmental toxicity, and neurotoxicity. Environ. Mol. Mutagen. 2015, 56, 125–148. [Google Scholar] [CrossRef] [PubMed]
- Wu, L.; Wen, W.; Wang, X.; Huang, D.; Cao, J.; Qi, X.; Shen, S. Ultrasmall iron oxide nanoparticles cause significant toxicity by specifically inducing acute oxidative stress to multiple organs. Part. Fibre Toxicol. 2022, 19, 24. [Google Scholar] [CrossRef]
- Luengo, Y.; Nardecchia, S.; Morales, M.D.; Serrano, M.C. Different cell responses induced by exposure to maghemite nanoparticles. Nanoscale 2013, 5, 11428–11437. [Google Scholar] [CrossRef]
- Balas, M.; Ciobanu, C.S.; Burtea, C.; Stan, M.S.; Bezirtzoglou, E.; Predoi, D.; Dinischiotu, A. Synthesis, Characterization, and Toxicity Evaluation of Dextran-Coated Iron Oxide Nanoparticles. Metals 2017, 7, 63. [Google Scholar] [CrossRef] [Green Version]
- Foy, S.P.; Labhasetwar, V. Oh the irony: Iron as a cancer cause or cure? Biomaterials 2011, 32, 9155–9158. [Google Scholar] [CrossRef] [PubMed]
- Marengo, B.; Nitti, M.; Furfaro, A.L.; Colla, R.; Ciucis, C.D.; Marinari, U.M.; Pronzato, M.A.; Traverso, N.; Domenicotti, C. Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy. Oxidative Med. Cell. Longev. 2016, 2016, 6235641. [Google Scholar] [CrossRef] [PubMed]
- Sollberger, G.; Strittmatter, G.E.; Garstkiewicz, M.; Sand, J.; Beer, H.D. Caspase-1: The inflammasome and beyond. Innate Immun. 2014, 20, 115–125. [Google Scholar] [CrossRef] [PubMed]
- Rubartelli, A. Redox control of NLRP3 inflammasome activation in health and disease. J. Leukoc. Biol. 2012, 92, 951–958. [Google Scholar] [CrossRef]
- Biebl, M.M.; Buchner, J. Structure, Function, and Regulation of the Hsp90 Machinery. Cold Spring Harb. Perspect. Biol. 2019, 11, a034017. [Google Scholar] [CrossRef]
- Sharma, D.; Masison, D.C. Hsp70 structure, function, regulation and influence on yeast prions. Protein Pept. Lett. 2009, 16, 571–581. [Google Scholar] [CrossRef]
- Bozaykut, P.; Sozen, E.; Kaga, E.; Ece, A.; Ozaltin, E.; Bergquist, J.; Ozer, N.K.; Yilmaz, B.K. HSP70 Inhibition Leads to the Activation of Proteasomal System under Mild Hyperthermia Conditions in Young and Senescent Fibroblasts. Oxidative Med. Cell. Longev. 2020, 2020, 9369524. [Google Scholar] [CrossRef]
- Zhou, C.; Sun, H.; Zheng, C.; Gao, J.; Fu, Q.; Hu, N.; Shao, X.; Zhou, Y.; Xiong, J.; Nie, K.; et al. Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth. Cell Death Dis. 2018, 9, 161. [Google Scholar] [CrossRef]
- Fang, J.; Seki, T.; Maeda, H. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv. Drug Deliv. Rev. 2009, 61, 290–302. [Google Scholar] [CrossRef]
- Predoi, D. A Study on iron oxide nanoparticles coated with dextrin obtained by coprecipitation. Dig. J. Nanomater. Biostruct. 2007, 2, 169–173. [Google Scholar]
- Ciobanu, C.S.; Iconaru, S.L.; Gyorgy, E.; Radu, M.; Costache, M.; Dinischiotu, A.; Le Coustumer, P.; Lafdi, K.; Predoi, D. Biomedical properties and preparation of iron oxide-dextran nanostructures by MAPLE technique. Chem. Cent. J. 2012, 6, 17. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Butoi, B.; Ciobanu, C.S.; Iconaru, S.L.; Negrilă, C.C.; Badea, M.A.; Balas, M.; Dinischiotu, A.; Predoi, G.; Bita, B.; Groza, A.; et al. Iron-Oxide-Nanoparticles-Doped Polyaniline Composite Thin Films. Polymers 2022, 14, 1821. [Google Scholar] [CrossRef] [PubMed]
- Prodan, A.M.; Iconaru, S.L.; Chifiriuc, C.M.; Bleotu, C.; Ciobanu, C.S.; Motelica-Heino, M.; Sizaret, S.; Predoi, D. Magnetic Properties and Biological Activity Evaluation of Iron Oxide Nanoparticles. J. Nanomater. 2013, 2013, 893970. [Google Scholar] [CrossRef]
- Iconaru, S.L.; Prodan, A.M.; Motelica-Heino, M.; Sizaret, S.; Predoi, D. Synthesis and characterization of polysaccharide-maghemite composite nanoparticles and their antibacterial properties. Nanoscale Res. Lett. 2012, 7, 576–584. [Google Scholar] [CrossRef]
- Boutry, S.; Burtea, C.; Mahieu, I.; Murariu, O.; Laurent, S.; Elst, L.V.; Muller, R.N. How to quantify iron in an aqueous or biological matrix: A technical note. Contrast Media Mol. Imag. 2009, 4, 299–304. [Google Scholar] [CrossRef]
- Dinischiotu, A.; Stanca, L.; Gradinaru, D.; Petrache, S.N.; Radu, M.; Serban, A.I. Lipid peroxidation due to in vitro and in vivo exposure of biological samples to nanoparticles. In Oxidative Stress and Nanotechnology; Armstrong, D., Bharali, D.J., Eds.; Springer: New York, NY, USA, 2013; Volume 1028, pp. 155–164. [Google Scholar]
- Vanderlinde, R.E. Measurement of total lactate dehydrogenase activity. Ann. Clin. Lab. Sci. 1985, 15, 13–31. [Google Scholar]
- Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal. Biochem. 1976, 72, 248–254. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Balas, M.; Predoi, D.; Burtea, C.; Dinischiotu, A. New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications. Int. J. Mol. Sci. 2023, 24, 3307. https://doi.org/10.3390/ijms24043307
Balas M, Predoi D, Burtea C, Dinischiotu A. New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications. International Journal of Molecular Sciences. 2023; 24(4):3307. https://doi.org/10.3390/ijms24043307
Chicago/Turabian StyleBalas, Mihaela, Daniela Predoi, Carmen Burtea, and Anca Dinischiotu. 2023. "New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications" International Journal of Molecular Sciences 24, no. 4: 3307. https://doi.org/10.3390/ijms24043307